2023 Q3 Form 10-Q Financial Statement

#000000708423000028 Filed on July 25, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $21.70B $25.19B
YoY Change -12.11% -7.67%
Cost Of Revenue $19.89B $23.31B
YoY Change -13.06% -7.45%
Gross Profit $1.810B $1.883B
YoY Change -0.06% -10.33%
Gross Profit Margin 8.34% 7.48%
Selling, General & Admin $815.0M $841.0M
YoY Change -0.37% 3.32%
% of Gross Profit 45.03% 44.66%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $261.0M $262.0M
YoY Change 0.38% 1.95%
% of Gross Profit 14.42% 13.91%
Operating Expenses $815.0M $841.0M
YoY Change -0.37% 3.32%
Operating Profit $995.0M $1.042B
YoY Change 0.2% -18.97%
Interest Expense $155.0M $180.0M
YoY Change 59.79% 146.58%
% of Operating Profit 15.58% 17.27%
Other Income/Expense, Net $35.00M $37.00M
YoY Change -47.76% -55.42%
Pretax Income $1.031B $1.132B
YoY Change -16.18% -25.48%
Income Tax $207.0M $204.0M
% Of Pretax Income 20.08% 18.02%
Net Earnings $821.0M $927.0M
YoY Change -20.37% -25.0%
Net Earnings / Revenue 3.78% 3.68%
Basic Earnings Per Share $1.52 $1.70
Diluted Earnings Per Share $1.52 $1.70
COMMON SHARES
Basic Shares Outstanding 536.1M shares 544.6M shares
Diluted Shares Outstanding 540.0M shares 546.0M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.498B $1.426B
YoY Change 36.31% 57.4%
Cash & Equivalents $1.498B $1.426B
Short-Term Investments
Other Short-Term Assets $5.618B $5.081B
YoY Change -8.86% -26.85%
Inventory $11.22B $11.90B
Prepaid Expenses $614.0M $349.0M
Receivables $4.443B $4.110B
Other Receivables $1.942B $2.172B
Total Short-Term Assets $30.52B $30.69B
YoY Change -11.71% -18.49%
LONG-TERM ASSETS
Property, Plant & Equipment $10.22B $10.13B
YoY Change 6.38% 4.62%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $5.469B $5.665B
YoY Change 0.74% 3.68%
Other Assets $1.351B $1.341B
YoY Change -0.22% -9.88%
Total Long-Term Assets $24.57B $24.81B
YoY Change 3.52% 2.61%
TOTAL ASSETS
Total Short-Term Assets $30.52B $30.69B
Total Long-Term Assets $24.57B $24.81B
Total Assets $55.09B $55.50B
YoY Change -5.51% -10.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.252B $5.079B
YoY Change -19.73% -9.32%
Accrued Expenses $1.475B $1.315B
YoY Change -3.72% -8.36%
Deferred Revenue
YoY Change
Short-Term Debt $116.0M $125.0M
YoY Change -35.91% -94.69%
Long-Term Debt Due $1.000M $301.0M
YoY Change -99.89% -72.74%
Total Short-Term Liabilities $18.11B $18.79B
YoY Change -21.06% -26.78%
LONG-TERM LIABILITIES
Long-Term Debt $8.224B $8.244B
YoY Change 7.21% 2.26%
Other Long-Term Liabilities $929.0M $984.0M
YoY Change -8.56% -10.71%
Total Long-Term Liabilities $11.41B $11.43B
YoY Change 3.24% -0.43%
TOTAL LIABILITIES
Total Short-Term Liabilities $18.11B $18.79B
Total Long-Term Liabilities $11.41B $11.43B
Total Liabilities $29.51B $30.22B
YoY Change -13.16% -18.63%
SHAREHOLDERS EQUITY
Retained Earnings $24.70B $24.24B
YoY Change 6.93% 4.09%
Common Stock $3.140B $3.128B
YoY Change 0.96% 2.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $25.23B $24.94B
YoY Change
Total Liabilities & Shareholders Equity $55.09B $55.50B
YoY Change -5.51% -10.24%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $821.0M $927.0M
YoY Change -20.37% -25.0%
Depreciation, Depletion And Amortization $261.0M $262.0M
YoY Change 0.38% 1.95%
Cash From Operating Activities $992.0M $2.509B
YoY Change -75.34% 372.5%
INVESTING ACTIVITIES
Capital Expenditures $441.0M $287.0M
YoY Change -229.33% -201.41%
Acquisitions
YoY Change
Other Investing Activities -$9.000M $4.000M
YoY Change -122.5% -118.18%
Cash From Investing Activities -$450.0M -$283.0M
YoY Change 49.5% -7.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -669.0M -2.729B
YoY Change -82.65% 49.37%
NET CHANGE
Cash From Operating Activities 992.0M 2.509B
Cash From Investing Activities -450.0M -283.0M
Cash From Financing Activities -669.0M -2.729B
Net Change In Cash -127.0M -503.0M
YoY Change -4.51% -68.58%
FREE CASH FLOW
Cash From Operating Activities $992.0M $2.509B
Capital Expenditures $441.0M $287.0M
Free Cash Flow $551.0M $2.222B
YoY Change -87.37% 172.97%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.90
adm Proceedsfromsaleofbusinessandassets
Proceedsfromsaleofbusinessandassets
17000000 usd
adm Proceedsfromsaleofbusinessandassets
Proceedsfromsaleofbusinessandassets
12000000 usd
us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
6000000 usd
us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
58000000 usd
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
133000000 usd
us-gaap Proceeds From Issuance Of Long Term Debt And Capital Securities Net
ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet
500000000 usd
us-gaap Proceeds From Issuance Of Long Term Debt And Capital Securities Net
ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet
751000000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
662000000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-371000000 usd
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
1414000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1001000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
200000000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
494000000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
453000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-103000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-21000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2131000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1491000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-3000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1846000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
169000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7033000000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7454000000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1426000000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
906000000 usd
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3761000000 usd
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
6717000000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5187000000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7623000000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
24896000000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
957000000 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.45
CY2023Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
246000000 usd
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
654000000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
21000000 usd
CY2023Q2 adm Stock Option Exercises Net Of Taxes Value
StockOptionExercisesNetOfTaxesValue
1000000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
24975000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
24317000000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2172000000 usd
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
494000000 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1005000000 usd
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
86000000 usd
adm Stock Option Exercises Net Of Taxes Value
StockOptionExercisesNetOfTaxesValue
-107000000 usd
us-gaap Stockholders Equity Other
StockholdersEquityOther
-6000000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
23755000000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1060000000 usd
CY2022Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.40
CY2022Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
227000000 usd
CY2022Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
200000000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
28000000 usd
CY2022Q2 adm Stock Option Exercises Net Of Taxes Value
StockOptionExercisesNetOfTaxesValue
10000000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
24426000000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
22508000000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2502000000 usd
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.80
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
453000000 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
200000000 usd
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
97000000 usd
adm Stock Option Exercises Net Of Taxes Value
StockOptionExercisesNetOfTaxesValue
-26000000 usd
us-gaap Stockholders Equity Other
StockholdersEquityOther
2000000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
24426000000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
182000000 usd
CY2023Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
9000000 usd
CY2022Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
22000000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
16000000 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
4000000 usd
CY2023Q2 adm Accounts Receivable Allowance For Credit Loss Foreign Currency
AccountsReceivableAllowanceForCreditLossForeignCurrency
0 usd
CY2022Q2 adm Accounts Receivable Allowance For Credit Loss Foreign Currency
AccountsReceivableAllowanceForCreditLossForeignCurrency
-2000000 usd
CY2023Q2 adm Accounts Receivable Allowance For Credit Loss Other Adjustments
AccountsReceivableAllowanceForCreditLossOtherAdjustments
-1000000 usd
CY2022Q2 adm Accounts Receivable Allowance For Credit Loss Other Adjustments
AccountsReceivableAllowanceForCreditLossOtherAdjustments
11000000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
174000000 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
164000000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
199000000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
122000000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
13000000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
44000000 usd
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
1000000 usd
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
1000000 usd
CY2023Q2 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
7592000000 usd
CY2022Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
6975000000 usd
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4310000000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
7796000000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
11902000000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
14771000000 usd
CY2022Q4 us-gaap Equity Securities Fv Ni And Without Readily Determinable Fair Value
EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue
488000000 usd
CY2022Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
3000000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
37000000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
0 usd
CY2023Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
0 usd
CY2023Q2 adm Payables Under Supplier Finance Program
PayablesUnderSupplierFinanceProgram
310000000 usd
CY2022Q4 adm Payables Under Supplier Finance Program
PayablesUnderSupplierFinanceProgram
196000000 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
286000000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
694000000 usd
CY2023Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
311000000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
673000000 usd
CY2022Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
335000000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
581000000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25190000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
49262000000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27284000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
50934000000 usd
CY2023Q2 us-gaap Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
780000000 usd
CY2023Q2 us-gaap Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-545000000 usd
CY2022Q2 us-gaap Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
253000000 usd
CY2022Q2 us-gaap Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-294000000 usd
us-gaap Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
1400000000 usd
us-gaap Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-800000000 usd
us-gaap Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
1700000000 usd
us-gaap Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-1700000000 usd
CY2023Q2 us-gaap Revenues
Revenues
25190000000 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
23307000000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
37000000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
180000000 usd
CY2023Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
217000000 usd
CY2022Q2 us-gaap Revenues
Revenues
27284000000 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
25184000000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
83000000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
73000000 usd
CY2022Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
1239000000 usd
us-gaap Revenues
Revenues
49262000000 usd
us-gaap Cost Of Revenue
CostOfRevenue
45299000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
81000000 usd
us-gaap Interest Expense
InterestExpense
327000000 usd
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
730000000 usd
us-gaap Revenues
Revenues
50934000000 usd
us-gaap Cost Of Revenue
CostOfRevenue
46937000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
116000000 usd
us-gaap Interest Expense
InterestExpense
165000000 usd
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
551000000 usd
CY2023Q2 adm Corn Processed Per Month
CornProcessedPerMonth
65000000 bu
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
23307000000 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
25184000000 usd
us-gaap Cost Of Revenue
CostOfRevenue
45299000000 usd
us-gaap Cost Of Revenue
CostOfRevenue
46937000000 usd
us-gaap Notional Amount Of Nonderivative Instruments
NotionalAmountOfNonderivativeInstruments
900000000 eur
CY2022 us-gaap Notional Amount Of Nonderivative Instruments
NotionalAmountOfNonderivativeInstruments
1300000000 eur
CY2023Q2 adm Foreign Debtusedin Net Investment Hedge Netof Tax
ForeignDebtusedinNetInvestmentHedgeNetofTax
208000000 usd
CY2022Q4 adm Foreign Debtusedin Net Investment Hedge Netof Tax
ForeignDebtusedinNetInvestmentHedgeNetofTax
228000000 usd
CY2023Q2 us-gaap Derivative Assets
DerivativeAssets
1825000000 usd
CY2022Q4 us-gaap Derivative Assets
DerivativeAssets
1704000000 usd
CY2023Q2 us-gaap Margin Deposit Assets
MarginDepositAssets
460000000 usd
CY2022Q4 us-gaap Margin Deposit Assets
MarginDepositAssets
723000000 usd
CY2023Q2 us-gaap Receivables From Customers
ReceivablesFromCustomers
1068000000 usd
CY2022Q4 us-gaap Receivables From Customers
ReceivablesFromCustomers
1309000000 usd
CY2023Q2 us-gaap Notes Receivable Net
NotesReceivableNet
161000000 usd
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
235000000 usd
CY2023Q2 us-gaap Premiums Receivable At Carrying Value
PremiumsReceivableAtCarryingValue
71000000 usd
CY2022Q4 us-gaap Premiums Receivable At Carrying Value
PremiumsReceivableAtCarryingValue
54000000 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
349000000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
443000000 usd
CY2023Q2 adm Biodieseltaxcredit
Biodieseltaxcredit
177000000 usd
CY2022Q4 adm Biodieseltaxcredit
Biodieseltaxcredit
68000000 usd
CY2023Q2 adm Taxreceivables
Taxreceivables
544000000 usd
CY2022Q4 adm Taxreceivables
Taxreceivables
616000000 usd
CY2023Q2 us-gaap Other Receivables
OtherReceivables
328000000 usd
CY2022Q4 us-gaap Other Receivables
OtherReceivables
361000000 usd
CY2023Q2 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
98000000 usd
CY2022Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
153000000 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
5081000000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
5666000000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
3000000 usd
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
3000000 usd
CY2023Q2 adm Interestonfinancingreceivables
Interestonfinancingreceivables
4000000 usd
adm Interestonfinancingreceivables
Interestonfinancingreceivables
10000000 usd
CY2022Q2 adm Interestonfinancingreceivables
Interestonfinancingreceivables
4000000 usd
adm Interestonfinancingreceivables
Interestonfinancingreceivables
8000000 usd
adm Accrued Expenses And Other Payables Disclosure
AccruedExpensesAndOtherPayablesDisclosure
Accrued Expenses and Other Payables<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the items in accrued expenses and other payables:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:69.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.019%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In millions)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses on derivative contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,626</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,543 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">302</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">268</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other taxes payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">178</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance claims payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">294</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">286</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">694 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accruals and payables</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,315</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,476 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,269</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,795 </span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>
CY2023Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
1626000000 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
1543000000 usd
CY2023Q2 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
302000000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
475000000 usd
CY2023Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
268000000 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
248000000 usd
CY2023Q2 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
178000000 usd
CY2022Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
136000000 usd
CY2023Q2 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
294000000 usd
CY2022Q4 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
223000000 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
286000000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
694000000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1315000000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1476000000 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4269000000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4795000000 usd
CY2023Q2 adm Fair Value Of Debt Below Carrying Value
FairValueOfDebtBelowCarryingValue
300000000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.180
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.170
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.184
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.174
adm Minimum Corporate Income Tax Rate
MinimumCorporateIncomeTaxRate
0.15
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2463000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Before Reclassifications Before Tax
OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
12000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Investment Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
-52000000 usd
CY2023Q2 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
-37000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-33000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
30000000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2433000000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2509000000 usd
us-gaap Other Comprehensive Income Loss Before Reclassifications Before Tax
OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
47000000 usd
us-gaap Other Comprehensive Income Loss Net Investment Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
-130000000 usd
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
-110000000 usd
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-49000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
76000000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2433000000 usd
CY2023Q2 adm Gain Losson Saleand Revaluationof Assets
GainLossonSaleandRevaluationofAssets
21000000 usd
CY2022Q2 adm Gain Losson Saleand Revaluationof Assets
GainLossonSaleandRevaluationofAssets
5000000 usd
adm Gain Losson Saleand Revaluationof Assets
GainLossonSaleandRevaluationofAssets
32000000 usd
adm Gain Losson Saleand Revaluationof Assets
GainLossonSaleandRevaluationofAssets
5000000 usd
CY2023Q2 adm Othernet
Othernet
16000000 usd
CY2022Q2 adm Othernet
Othernet
78000000 usd
adm Othernet
Othernet
49000000 usd
adm Othernet
Othernet
111000000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
37000000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
83000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
81000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
116000000 usd
CY2023Q2 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-5000000 usd
us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-9000000 usd
CY2022Q2 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-6000000 usd
us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-12000000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2023Q2 us-gaap Revenues
Revenues
25190000000 usd
CY2022Q2 us-gaap Revenues
Revenues
27284000000 usd
us-gaap Revenues
Revenues
49262000000 usd
us-gaap Revenues
Revenues
50934000000 usd
CY2023Q2 us-gaap Revenues
Revenues
25190000000 usd
CY2022Q2 us-gaap Revenues
Revenues
27284000000 usd
us-gaap Revenues
Revenues
49262000000 usd
us-gaap Revenues
Revenues
50934000000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1132000000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1519000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2529000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2790000000 usd
CY2023Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
43000000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
46000000 usd
CY2023Q2 us-gaap Restructuring Charges
RestructuringCharges
17000000 usd
us-gaap Restructuring Charges
RestructuringCharges
21000000 usd
CY2023Q2 us-gaap Transfer Of Financial Assets Accounted For As Sales Fair Value Of Derecognized Assets
TransferOfFinancialAssetsAccountedForAsSalesFairValueOfDerecognizedAssets
2100000000 usd
CY2022Q4 us-gaap Transfer Of Financial Assets Accounted For As Sales Fair Value Of Derecognized Assets
TransferOfFinancialAssetsAccountedForAsSalesFairValueOfDerecognizedAssets
2600000000 usd
adm Amount Of Receivables Sold
AmountOfReceivablesSold
28800000000 usd
adm Amount Of Receivables Sold
AmountOfReceivablesSold
29300000000 usd
us-gaap Proceeds From Sale Of Other Receivables
ProceedsFromSaleOfOtherReceivables
28400000000 usd
us-gaap Proceeds From Sale Of Other Receivables
ProceedsFromSaleOfOtherReceivables
28200000000 usd
CY2023Q2 us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
-11000000 usd
us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
-34000000 usd
CY2022Q2 us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
-3000000 usd
us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
-8000000 usd

Files In Submission

Name View Source Status
0000007084-23-000028-index-headers.html Edgar Link pending
0000007084-23-000028-index.html Edgar Link pending
0000007084-23-000028.txt Edgar Link pending
0000007084-23-000028-xbrl.zip Edgar Link pending
adm-20230630.htm Edgar Link pending
adm-20230630.xsd Edgar Link pending
adm-20230630_g1.jpg Edgar Link pending
adm-ex311_2023630xq2.htm Edgar Link pending
adm-ex312_2023630xq2.htm Edgar Link pending
adm-ex321_2023630xq2.htm Edgar Link pending
adm-20230630_cal.xml Edgar Link unprocessable
adm-20230630_def.xml Edgar Link unprocessable
adm-20230630_htm.xml Edgar Link completed
adm-ex322_2023630xq2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
adm-20230630_lab.xml Edgar Link unprocessable
adm-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable